220 related articles for article (PubMed ID: 25604666)
1. Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport.
Midde NM; Yuan Y; Quizon PM; Sun WL; Huang X; Zhan CG; Zhu J
J Neuroimmune Pharmacol; 2015 Mar; 10(1):122-35. PubMed ID: 25604666
[TBL] [Abstract][Full Text] [Related]
2. Mutation of tyrosine 470 of human dopamine transporter is critical for HIV-1 Tat-induced inhibition of dopamine transport and transporter conformational transitions.
Midde NM; Huang X; Gomez AM; Booze RM; Zhan CG; Zhu J
J Neuroimmune Pharmacol; 2013 Sep; 8(4):975-87. PubMed ID: 23645138
[TBL] [Abstract][Full Text] [Related]
3. Mutational effects of human dopamine transporter at tyrosine88, lysine92, and histidine547 on basal and HIV-1 Tat-inhibited dopamine transport.
Sun WL; Quizon PM; Yuan Y; Strauss MJ; McCain R; Zhan CG; Zhu J
Sci Rep; 2019 Mar; 9(1):3843. PubMed ID: 30846720
[TBL] [Abstract][Full Text] [Related]
4. Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat-inhibited Dopamine Transport.
Quizon PM; Yuan Y; Zhu Y; Zhou Y; Strauss MJ; Sun WL; Zhan CG; Zhu J
J Neuroimmune Pharmacol; 2021 Dec; 16(4):854-869. PubMed ID: 33537927
[TBL] [Abstract][Full Text] [Related]
5. Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter.
Sun WL; Quizon PM; Yuan Y; Zhang W; Ananthan S; Zhan CG; Zhu J
Sci Rep; 2017 Jun; 7(1):3694. PubMed ID: 28623359
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport.
Quizon PM; Sun WL; Yuan Y; Midde NM; Zhan CG; Zhu J
Sci Rep; 2016 Dec; 6():39048. PubMed ID: 27966610
[TBL] [Abstract][Full Text] [Related]
7. SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic mice.
Zhu J; Quizon PM; Wang Y; Adeniran CA; Strauss MJ; Jiménez-Torres AC; Patel P; Cirino TJ; Eans SO; Hammond HR; Deliscar LS; O'Hara P; Saini SK; Ofori E; Vekariya RH; Zhang S; Moukha-Chafiq O; Nguyen TH; Ananthan S; Augelli-Szafran CE; Zhan CG; McLaughlin JP
Neuropharmacology; 2022 Dec; 220():109239. PubMed ID: 36126727
[TBL] [Abstract][Full Text] [Related]
8. Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function.
Strauss MJ; Porter KD; Quizon PM; Davis SE; Lin S; Yuan Y; Martinez-Muniz GA; Sun WL; Zhan CG; Zhu J
PLoS One; 2022; 17(9):e0275182. PubMed ID: 36170295
[TBL] [Abstract][Full Text] [Related]
9. The role of human dopamine transporter in NeuroAIDS.
Zhu J; Ananthan S; Zhan CG
Pharmacol Ther; 2018 Mar; 183():78-89. PubMed ID: 28987321
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes.
Zhu J; Mactutus CF; Wallace DR; Booze RM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1071-83. PubMed ID: 19325033
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of HIV-1 Tat interacting with human dopamine transporter.
Yuan Y; Huang X; Midde NM; Quizon PM; Sun WL; Zhu J; Zhan CG
ACS Chem Neurosci; 2015 Apr; 6(4):658-665. PubMed ID: 25695767
[TBL] [Abstract][Full Text] [Related]
12. Role of Histidine 547 of Human Dopamine Transporter in Molecular Interaction with HIV-1 Tat and Dopamine Uptake.
Yuan Y; Quizon PM; Sun WL; Yao J; Zhu J; Zhan CG
Sci Rep; 2016 Jun; 6():27314. PubMed ID: 27250920
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes.
Midde NM; Gomez AM; Zhu J
J Neuroimmune Pharmacol; 2012 Sep; 7(3):629-39. PubMed ID: 22570010
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum.
Zhu J; Yuan Y; Midde NM; Gomez AM; Sun WL; Quizon PM; Zhan CG
J Neurovirol; 2016 Jun; 22(3):282-92. PubMed ID: 26501780
[TBL] [Abstract][Full Text] [Related]
15. Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes.
Doolen S; Zahniser NR
J Pharmacol Exp Ther; 2001 Mar; 296(3):931-8. PubMed ID: 11181926
[TBL] [Abstract][Full Text] [Related]
16. An N-terminal threonine mutation produces an efflux-favorable, sodium-primed conformation of the human dopamine transporter.
Fraser R; Chen Y; Guptaroy B; Luderman KD; Stokes SL; Beg A; DeFelice LJ; Gnegy ME
Mol Pharmacol; 2014 Jul; 86(1):76-85. PubMed ID: 24753048
[TBL] [Abstract][Full Text] [Related]
17. Site-directed mutations near transmembrane domain 1 alter conformation and function of norepinephrine and dopamine transporters.
Guptaroy B; Fraser R; Desai A; Zhang M; Gnegy ME
Mol Pharmacol; 2011 Mar; 79(3):520-32. PubMed ID: 21149640
[TBL] [Abstract][Full Text] [Related]
18. [
Strauss M; O'Donovan B; Ma Y; Xiao Z; Lin S; Bardo MT; Ortinski PI; McLaughlin JP; Zhu J
J Pharmacol Exp Ther; 2020 Aug; 374(2):241-251. PubMed ID: 32461322
[TBL] [Abstract][Full Text] [Related]
19. Different effects of selective dopamine uptake inhibitors, GBR 12909 and WIN 35428, on HIV-1 Tat toxicity in rat fetal midbrain neurons.
Aksenov MY; Aksenova MV; Silvers JM; Mactutus CF; Booze RM
Neurotoxicology; 2008 Nov; 29(6):971-7. PubMed ID: 18606182
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
